Ashwagandha‐Induced Herb‐Induced Liver Injury Assessed With the Updated 2016 RUCAM
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Case Reports in Hepatology
- Vol. 2026 (1) , 8417352
Abstract
Ashwagandha‐induced herb‐induced liver injury (HILI) has increasingly been reported; however, many published cases show methodological variability in causality assessment and limited clinicopathological correlation. We present a case of ashwagandha‐associated liver injury with systematic causality evaluation using the updated 2016 Roussel Uclaf Causality Assessment Method (RUCAM) and comprehensive clinicopathological correlation. A previously healthy 27‐year‐old woman developed jaundice and generalized pruritus after consuming ashwagandha for three days. Infectious, autoimmune, and metabolic etiologies were excluded. Abdominal magnetic resonance imaging showed no structural abnormalities, while liver biopsy demonstrated a classic cholestatic pattern without fibrosis. Causality assessment using the updated 2016 RUCAM yielded a score of 7 points, consistent with probable HILI. The patient received symptomatic management, corticosteroids, and azathioprine, with progressive clinical and biochemical improvement. This case highlights the value of a systematic causality approach using updated RUCAM criteria together with complete clinicopathological correlation to strengthen diagnostic confidence in suspected HILI associated with herbal supplements.Keywords
This publication has 12 references indexed in Scilit:
- Ashwagandha-Associated Acute Liver Injury: A Case Report and Literature ReviewBiomedical Journal of Scientific & Technical Research, 2025
- Challenges in herbal‐induced liver injury identification and preventionLiver International, 2024
- Visual Management Board Implementation to Enhance High Reliability at a Large VA Health Care SystemFederal Practitioner, 2024
- A comprehensive review on the hepatotoxicity of herbs used in the Indian (Ayush) systems of alternative medicineMedicine, 2024
- Ashwagandha-induced liver injury—A case series from India and literature reviewHepatology Communications, 2023
- Ashwagandha‐induced acute liver injury: A case reportClinical Case Reports, 2023
- Liver Dangers of Herbal Products: A Case Report of Ashwagandha-Induced Liver InjuryInternational Journal of Environmental Research and Public Health, 2023
- Ashwagandha-Associated Acute Liver Failure Requiring Liver TransplantationAmerican Journal of Therapeutics, 2022
- DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of Withania somnifera (Ashwagandha)Current Research in Toxicology, 2021
- A case of drug-induced liver injury with prolonged severe intrahepatic cholestasis induced by AshwagandhaKanzo, 2017